Bulletin
Investor Alert

London Markets Open in:

Topics

Pfizer Inc.

/marketstate/country/us

After Hours

7:59 p.m.

PFE
Pfizer Inc.
/zigman2/quotes/202877789/composite

$

44.35

Change

+0.40 +0.91%

Volume

Volume 3.00m

Quotes are delayed by 20 min

/zigman2/quotes/202877789/composite

Previous close

$ 43.92

$ 43.95

Change

+0.03 +0.07%

Day low

Day high

$43.83

$44.39

Open

52 week low

52 week high

$32.78

$51.86

Open

Video

Covid Vaccine Efficacy Numbers, Explained

  • Covid Vaccine Efficacy Numbers, Explained Covid Vaccine Efficacy Numbers, Explained 6:00
    Covid-19 Boosters Are Coming: Here's What to Know Covid-19 Boosters Are Coming: Here's What to Know 4:46
    Covid-19 Booster Shots: When Might You Need One and Why? Covid-19 Booster Shots: When Might You Need One and Why? 6:50
    The Science Behind Why the Delta Variant Is Spreading Covid-19 Faster The Science Behind Why the Delta Variant Is Spreading Covid-19 Faster 7:01
5:08 p.m. Sept. 22, 2021 - By Jaimy Lee
Whether COVID-19 boosters get approved or not, Pfizer and Moderna have already made their moneyIt's likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesn’t mean companies like Moderna and Pfizer will report an unexpected revenue windfall this year.
4:21 p.m. Sept. 22, 2021 - MarketWatch.com
FDA backs Pfizer COVID-19 boosters for seniors and those at high riskThe U.S. has moved a step closer to offering booster doses of Pfizer’s COVID-19 vaccine to seniors and others at high risk from the virus.
1:15 p.m. Sept. 22, 2021 - By MarketWatch Automation
1:09 p.m. Sept. 22, 2021 - By MarketWatch Automation
1:00 p.m. Sept. 22, 2021 - By MarketWatch
Why the debt limit fight makes Washington a stock-market ‘wild card’The potential for another white-knuckle flirtation with a U.S. default via a debt-ceiling showdown is helping to raise policy uncertainty. The good news, is that rising uncertainty has traditionally been a buying opportunity, says a top Wall Street technician.
1:00 p.m. Sept. 22, 2021 - By MarketWatch Automation
12:46 p.m. Sept. 22, 2021 - By MarketWatch Automation
12:41 p.m. Sept. 22, 2021 - By MarketWatch Automation
12:40 p.m. Sept. 22, 2021 - By MarketWatch Automation
12:36 p.m. Sept. 22, 2021 - By MarketWatch Automation
12:33 p.m. Sept. 22, 2021 - By MarketWatch Automation
12:32 p.m. Sept. 22, 2021 - By MarketWatch Automation
10:48 a.m. Sept. 22, 2021 - By Ciara Linnane
Global tally of COVID-19 cases nears 230 million, as Biden convenes virtual pandemic summit and doubles U.S. purchase of Pfizer vaccineThe global tally of confirmed cases of the coronavirus-borne illness COVID-19 was heading close to 230 million on Wednesday, as President Joe Biden prepared to host a virtual summit on the pandemic with world leaders gathered in New York for the United Nations General Assembly.
8:00 a.m. Sept. 22, 2021 - By MarketWatch
Global tally of COVID-19 cases nears 230 million, as Biden convenes virtual pandemic summit and doubles U.S. purchase of Pfizer vaccineThe global tally of confirmed cases of the coronavirus-borne illness COVID-19 was heading close to 230 million on Wednesday, as President Joe Biden prepared to host a virtual summit on the pandemic with world leaders gathered in New York for the United Nations General Assembly.
4:34 a.m. Sept. 22, 2021 - By Ciara Linnane
J&J says booster shot greatly improves its COVID-19 vaccine’s efficacy as experts await FDA decisionJohnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3 trial and the real world found protection against hospitalization and death is greatly improved by a booster jab of its one-shot vaccine.
3:34 a.m. Sept. 22, 2021 - By Jaimy Lee
CDC committee to meet today and Thursday to again discuss BioNTech and Pfizer's COVID-19 boosterA Centers for Disease Control and Prevention committee is Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE and Pfizer Inc.'s COVID-19 booster shot. The CDC's Advisory Committee on Immunization Practices sets out the guidelines for how vaccines should be used in the U.S. The Food and Drug Administration has not approved or authorized an extra dose of the BioNTech and Pfizer vaccine except in people who are immuno-compromised, and an influential FDA committee last week recommended that boosters to older people and those who are at higher risk of severe disease. Some experts have suggested that the FDA decision is coming this week.
3:06 a.m. Sept. 22, 2021 - MarketWatch.com
Biden doubling vaccine purchase, calls for more global shotsPresident Joe Biden is set to announce that the United States is doubling its purchase of Pfizer's COVID-19 shots to share with the world to 1 billion doses as he embraces the goal of vaccinating 70% of the global population within the next year.
2:30 a.m. Sept. 22, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 229.5 million and CDC advisers to meet to discuss boostersThe global tally for the coronavirus-borne illness climbed above 229.5 million on Wednesday, while the death toll rose to 4.71 million, according to . The U.S. continues to lead the world with a total of 42.4 million cases and 678,503 deaths. A team of advisers to the Centers for Disease Control and Prevention are scheduled to meet later Wednesday to decide on booster shots of the Pfizer/BioNTech COVID vaccine, The meeting comes after of a committee of advisers to the Food and Drug Administration, who rejected a proposal to offer boosters to everyone above the age of 16, but in favor of offering them to people older than 65 or with weakened immune systems. The CDC must now decide which patient groups might need boosters. The U.S. is now averaging 2,046 deaths a day, , the most since March 1, and are almost entirely unvaccinated people. India is second by cases after the U.S. at 33.5 million and has suffered 445,768 deaths. Brazil has second highest death toll at 591,440 and 21.2 million cases. Brazil's health minister Marcelo Queiroga tested positive for COVID on Tuesday in New York, where he was attending the U.N.'s General Assembly. In Europe, Russia has most fatalities at 196,235, followed by the U.K. at 135,793.
2:12 a.m. Sept. 22, 2021 - By Tomi Kilgore
Pfizer, BioNTech to provide additional 500 million COVID-19 vaccine doses to U.S. government for donationPfizer Inc. and BioNTech SE announced Wednesday plans to provide an additional 500 million doses of their COVID-19 vaccine to the U.S. government. The additional doses will be sold at "not-for-profit" prices, for donation to low- and lower-middle-income countries, as defined by Gavi's COVAX Advanced Market Commitment (AMC) and the 55 member states of the African Union. That brings the total number of doses to be supplied to the U.S. government for donation to 1 billion. Pfizer shares gained 0.6% in premarket trading and BioNTech's stock rose 0.6%. Delivery of the additional doses began in August, and the total 1 billion doses are expected to be delivered by the end of September 2022. The doses will be produced at Pfizer's facilities in Kalamazoo, Michigan, Andover, Massachusetts, Chesterfield, Missouri and McPherson, Kansas. Shares of Pfizer have climbed 19.3% year to date through Tuesday and BioNTech have rocketed 318.7%, while the S&P 500 has gained 15.9%.
2:04 a.m. Sept. 22, 2021
2:03 a.m. Sept. 22, 2021
1:15 p.m. Sept. 21, 2021 - By MarketWatch Automation
1:09 p.m. Sept. 21, 2021 - By MarketWatch Automation
1:00 p.m. Sept. 21, 2021 - By MarketWatch Automation
12:46 p.m. Sept. 21, 2021 - By MarketWatch Automation
12:41 p.m. Sept. 21, 2021 - By MarketWatch Automation
12:40 p.m. Sept. 21, 2021 - By MarketWatch Automation
12:36 p.m. Sept. 21, 2021 - By MarketWatch Automation
12:33 p.m. Sept. 21, 2021 - By MarketWatch Automation
12:32 p.m. Sept. 21, 2021 - By MarketWatch Automation
1:15 p.m. Sept. 20, 2021 - By MarketWatch Automation
1:10 p.m. Sept. 20, 2021 - By MarketWatch Automation
1:00 p.m. Sept. 20, 2021 - By MarketWatch Automation
12:59 p.m. Sept. 20, 2021 - By Joy Wiltermuth
Dow books worst day in 9 weeks as debt woes for China's Evergrande rattle stock marketU.S. stocks finish sharply lower Monday, but off the session's worst levels, as investors parse the potential impact of a reeling property developer in China and traders position ahead of a two-day meeting of Federal Reserve policy makers that begins Tuesday.
12:46 p.m. Sept. 20, 2021 - By MarketWatch Automation
12:41 p.m. Sept. 20, 2021 - By MarketWatch Automation
12:40 p.m. Sept. 20, 2021 - By MarketWatch Automation
12:36 p.m. Sept. 20, 2021 - By MarketWatch Automation
12:35 p.m. Sept. 20, 2021 - By Ciara Linnane
Upbeat result of COVID-19 vaccine trial in 5- to 11-year-olds tempered as U.S. daily death rate tops 2,000 for first time since March 1Positive results from a trial of the COVID-19 vaccine developed by Pfizer and German partner BioNTech in children 5 to 11 years old was tempered Monday by a rising average death rate, with the U.S. now seeing more than 2,000 fatalities a day for the first time since March 1.
12:33 p.m. Sept. 20, 2021 - By MarketWatch Automation
Browse topics:

Filter results by

Location

Us (330)

Europe (79)

Eu (52)

Asia Pacific (44)

China (34)

Uk (16)

Link to MarketWatch's Slice.